EDITORIAL ARTICLE
Lupus and pregnancy in the 21st century
More details
Hide details
Online publication date: 2014-03-23
Reumatologia 2014;52(1):1-3
KEYWORDS
ABSTRACT
Pregnancy outcome for women with systemic lupus erythematosus (SLE) has remarkably improved, with a significant increase in the success rate over 85% in recent years. However, pregnancy in patients with SLE remains a high-risk condition. Pre-pregnancy counselling, risk assessment, a multidisciplinary approach, and
early recognition of signs related to SLE complications (medical and/or obstetric), are essential cornerstones for both maternal and fetal successful outcomes.
REFERENCES (10)
1.
Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005; 32: 1709-1712.
2.
Ateka-Barrutia O, Khamashta MA. The challenge of pregnancy for patients with SLE. Lupus 2013; 22: 1295-1308.
3.
Clowse ME, Chakravarty E, Costenbader KH, et al. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012; 64: 668-674.
4.
Østensen M, Förger F. How safe are anti-rheumatic drugs during pregnancy? Curr Opin Pharmacol 2013; 13: 470-475.
5.
Østensen M, Förger F. Treatment with biologics of pregnant patients with rheumatic diseases. Curr Opin Rheumatol 2011; 23: 293-298.
6.
ClinicalTrials.gov identifier: NCT01532310.
7.
ClinicalTrials.gov identifier: NCT00198068.
8.
Palmsten K, Hernández-Díaz S, Kuriya B, et al. Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia. Arthritis Care Res (Hoboken) 2012; 64: 1730-1738.
9.
Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 2013; 27: 435-447.
10.
Ruiz-Irastorza G, Khamashta MA. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 2009; 23: 575-582.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.